Multi-source evidence verdict: D — Counter-Evidence.
Mainstream medicine consistently advises against biotin supplements for hair loss
in healthy adults.
What the evidence engine found
The card below was produced by 14 parallel sub-agents reviewing every authoritative
English-language source: FDA, EFSA, NHS, WHO, NIH Office of Dietary Supplements,
Mayo Clinic, Cleveland Clinic, Harvard Health, the American Academy of Dermatology,
and PubMed systematic reviews.
Biotin (Vitamin B7) for Hair Loss
CLM-COND-hair-loss-INT-biotin-001
🔴 D — Counter-Evidence
Cochrane / multiple MAs show no effect or harm — mainstream medicine against.
Status: Counter-Evidence
Mainstream medicine is against — UI must show "NOT recommended."
Composite Score
34%
Confidence
89%
Effect
⏸
Flags
Drug interaction
Key Citations (7)
NIH Office of Dietary Supplements
— stance: supportive
"Signs of biotin deficiency include skin rashes, hair loss, and brittle nails. Therefore, biotin supplements are often promoted for hair, skin, and nail health. However, these claims are supported, at best, by only a few case reports and sma…"
"Biotin in patient samples can cause incorrect lab test results. The FDA has received a report that one patient taking high levels of biotin died following falsely low troponin test results when a troponin test known to have biotin interfere…"
"Biotin contributes to the maintenance of normal hair / Biotin contributes to the maintenance of normal skin / Biotin contributes to the maintenance of normal mucous membranes — Article 13(1) authorised general function claims (Regulation (E…"
"You should be able to get all the biotin you need by eating a varied and balanced diet. The bacteria that live naturally in your bowel are able to make biotin, so it's not clear if you need any additional biotin from the diet."
"Clinical signs of deficiency include dermatitis of an erythematous and seborrheic type; conjunctivitis; alopecia; and central nervous system abnormalities... Toxicity is not a problem because of limited intestinal absorption of biotin."
Systematic reviews show no effect. Lipner 2018 (PMID 29856749)
and Patel 2017 (PMID 28879195) systematically reviewed every available trial and
found no RCT evidence that biotin grows hair in healthy adults.
Positive findings are limited to the rare inherited condition biotinidase
deficiency.
FDA safety communication (2017, updated 2019). High-dose biotin
(>5 mg/day, the dose in most "hair growth" gummies) interferes with
immunoassays — troponin, TSH, hCG, vitamin D, parathyroid hormone, and others.
The FDA documented one patient death from a missed myocardial
infarction (falsely low troponin reading). This alone changes the risk/benefit math.
Society alignment is unanimous. The American Academy of Dermatology
states bluntly: "you should only take biotin, iron, or zinc when your blood test
shows you have a deficiency." Mayo, Cleveland, Harvard Health, and the NIH Office
of Dietary Supplements all converge on the same position.
So why is biotin everywhere?
EFSA Article 13(1) functional claim. The EU did authorize the phrase
"biotin contributes to the maintenance of normal hair / skin / mucous membranes" —
but this is a biochemical function claim, NOT a therapeutic hair-loss claim.
The two are routinely conflated in consumer marketing.
Cost asymmetry. Minoxidil and finasteride require either a
prescription or sustained out-of-pocket spend. A bottle of biotin gummies costs $10–25.
The "vitamin = safe = effective" cognitive shortcut. It feels safer
than a drug, so people assume it must work. The FDA lab-interference signal shows
the safety assumption itself is wrong at high doses.
Oral finasteride 1 mg/day — FDA-approved (1997) for male
androgenetic alopecia, AAD first-line.
Iron, zinc, biotin — only if blood test confirms a deficiency.
Treat the deficiency, not the hair loss directly.
About this evidence verdict
This page's verdict card is produced by the
gpt-dict evidence engine, which runs 14 parallel
sub-agent layers for every (supplement, condition) pair: PubMed systematic review
search, regulatory positions (FDA, EFSA, NHS, WHO), authoritative clinics
(Mayo, Cleveland, Harvard, NIH ODS), professional society guidelines (AAD here),
drug interaction analysis, and AI-independent sanity review. Conflicts between
sources are auto-detected and flagged. Every quoted statement is preserved with
its source URL. The engine is schema-first: every layer's output is validated
against a JSON Schema before aggregation.